Table of Contents
Global Market Watch:
The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead.
Global IVC filters market forecasts to reach at US$0.55 billion by 2015 at a CAGR of 11.3% during the analysis period 2009-2015. The North American segment accounts for nearly 40% of the global value while Europe claims more than 25% of the market. Asia-Pacific is the fastest growing region with a CAGR of 13% driving a market value of US$0.14 billion by 2015. On a global scale, projections for retrievable IVC filter segment indicate a close to 60% by 2015 leaving the rest of the market to permanent type.
The report ‘Global Inferior Vena Cava (IVC) Filters - Market Growth Analysis, 2009-2015’ reviews the latest trends in IVC filters with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.
The report primarily focuses on:
• Emerging Market Trends
• Advancements in the Technological Space
• Market Demand Of The Segments (By-Region)
• Key Growth Areas and Market Size
• Region-Wise Demand Factor
• Key Competitors Edge
• Investment Strategies
The report covers the market analysis by product types.
The subdivisions are as:
- By Product
1. Retrievable Filters
2. Permanent IVC Filters
The period considered for the study analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 700 leading market players are identified and 95 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 83 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
Pipeline Overview Idiopathic pulmonary fibrosis (IPF) is referred to as progressive and chronic interstitial pneumonia without known cause. Pulmonary fibrosis is a disease in which tissue profound in lungs ...
Chronic Kidney Disease (CKD) Drugs Market (Drug Class - ACE Inhibitors, Angiotensin-II Receptor Blockers, Calcium Channel Blockers, Beta Blockers, Erythropoiesis - stimulating Agents (ESAs), and Diuretics; ...
The global cholesterol testing services market is expected to reach USD 17.5 billion by 2021 from USD 11.9 billion in 2016, growing at a CAGR of 8% during the forecast period. This market is segmented ...